A034940 Stock Overview
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ChoA Pharmaceutical Co., LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,250.00 |
| 52 Week High | ₩2,410.00 |
| 52 Week Low | ₩1,249.00 |
| Beta | 0.50 |
| 11 Month Change | -11.60% |
| 3 Month Change | -17.27% |
| 1 Year Change | -43.95% |
| 33 Year Change | -67.74% |
| 5 Year Change | -69.73% |
| Change since IPO | -38.12% |
Recent News & Updates
Shareholder Returns
| A034940 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -4.4% | 0.8% | -1.0% |
| 1Y | -43.9% | 22.1% | 3.2% |
Return vs Industry: A034940 underperformed the KR Pharmaceuticals industry which returned 22.1% over the past year.
Return vs Market: A034940 underperformed the KR Market which returned 3.2% over the past year.
Price Volatility
| A034940 volatility | |
|---|---|
| A034940 Average Weekly Movement | 3.5% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.6% |
Stable Share Price: A034940 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A034940's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 268 | Sung-Hwan Cho | www.choa.co.kr |
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers its products in the form of tablets, capsules, granules, syrups, solutions, drinkable ampoules, and sachets.
ChoA Pharmaceutical Co., LTD. Fundamentals Summary
| A034940 fundamental statistics | |
|---|---|
| Market cap | ₩38.72b |
| Earnings (TTM) | -₩12.89b |
| Revenue (TTM) | ₩61.03b |
0.6x
P/S Ratio-3.0x
P/E RatioIs A034940 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A034940 income statement (TTM) | |
|---|---|
| Revenue | ₩61.03b |
| Cost of Revenue | ₩39.79b |
| Gross Profit | ₩21.24b |
| Other Expenses | ₩34.13b |
| Earnings | -₩12.89b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -416.04 |
| Gross Margin | 34.80% |
| Net Profit Margin | -21.12% |
| Debt/Equity Ratio | 64.3% |
How did A034940 perform over the long term?
See historical performance and comparison